Home > Boards > US OTC > Miscellaneous >

Marathon Group Corporation. (PDPR)

PDPR RSS Feed
Add PDPR Price Alert      Hide Sticky   Hide Intro
Moderator: i_like_bb_stock, calluch, thetinman
Search This Board: 
Last Post: 6/11/2021 11:02:30 AM - Followers: 192 - Board type: Free - Posts Today: 0





 

MarathonRx is a wholly owned subsidiary of Marathon Group Corp. (OTC: PDPR), formed to explore the various opportunities that are available in the booming legal cannabis industry.  As the regulatory landscape continues to evolve for cannabis products and services, MarathonRx will leverage its parent company’s proven expertise in point-of-sale solutions, digital marketing, e-commerce, advertising and lead generation.
MarathonRx’s mission is to deliver the highest quality products and services to capture a piece of an industry that is projected to be worth over $100 billion by 2025 in the US and $146 billion worldwide. The company is actively seeking suppliers, partners and acquisitions in the legal cannabis industry.










 

BREAKING NEWS!  PDPR ENTERS THE RAPIDLY GROWING CBD INDUSTRY!
 








 

Marathon Group Corp. (OTC: PDPR) Has Retained Rage Marketing, Inc. For Strategic Growth Counseling

Waterbury, CT, Feb. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Marathon Group Corp. (PDPR) (the “Company” or “Marathon”) and its subsidiary MarathonRx, Inc. are pleased to announce they have retained Rage Marketing, Inc. (RMI), a cutting-edge marketing firm specializing in small-cap and micro-cap companies trading on the OTC Markets, as their strategic growth consultant. 

Under the terms of the agreement, RMI will expand Marathon Group’s presence with the nation’s brokerage and investment community, manage its growing shareholder base, develop and implement the Company’s overall corporate communications strategy.

Rage Marketing will also tap into its CBD industry network to assist with product development, identifying top quality suppliers and brand awareness.

“The addition of Rage Marketing solidifies our goal to aggressively take our share of the booming CBD industry,” states MacDonald Tudeme, President and CEO of Marathon Group. “Their expertise in business development and investor relations will assist us in building MarathonRx from the ground level to revenue generating in a short time,” he continued.

About MarathonRx, Inc.

MarathonRx is a wholly owned subsidiary of Marathon Group Corp. (PDPR), formed to explore the various opportunities that are available in the booming legal cannabis industry.  As the regulatory landscape continues to evolve for cannabis products and services, MarathonRx will leverage its parent company’s proven expertise in point-of-sale solutions, digital marketing, e-commerce, advertising and lead generation.

About Marathon Group Corp

Marathon Group Corp. (PDPR) is a Connecticut-based software company engaged in web property development, focused on solving problems faced by small and medium size businesses.

About Rage Marketing, Inc.

Rage Marketing Inc. is a cutting-edge marketing firm focused on Small-cap and Micro-cap companies trading on the OTC Markets. We are passionate about helping undervalued companies reach the audience they deserve. We know market trends. We are informed about the regulatory landscape. It's our business to understand the mindset of today's investors and how to deliver our clients’ message.

Safe Harbor Statement
The matters discussed, particularly information regarding future revenue, earnings, business plans and goals, consist of forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by these sections and involve risks and uncertainties, which could cause actual results to differ materially from the forward-looking information. Such statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management’s assumptions and the Company’s future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially. The Company undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking information contained herein is subject to the risk factors and uncertainties described in the Company’s filings with the Securities and Exchange Commission, which risk factors and uncertainties are incorporated by reference as though fully set forth herein.

http://globalfinance.zenfs.com/en_us/finance/us_aftp_globenewswire_emailnotif_live/ti?nf="NzUwMzc1OCMyNzM0NTQ0IzUwMDA1MjY2Mw==" "="" rel="nofollow" target="_blank">http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_GlobeNewsWire_EmailNotif_LIVE/ti?nf=NzUwMzc1OCMyNzM0NTQ0IzUwMDA1MjY2Mw=="; style="border-style:none; bottom:0px; height:1px; left:0px; position:absolute; right:0px; top:0px; transition-duration:0.42s; vertical-align:bottom; width:1px">

MacDonald Tudeme

jasmactt@gmail.com

Investor Relations:

 

Rage Marketing Inc.

info@ragemarketinginc.com

(800) 867-1851



 

MarathonRx’s mission is to deliver the highest quality products and services to
capture a piece of an industry that is projected to be worth over
$100 billion by 2025 in the US and $146 billion worldwide.

 


CBD 1,500 mg/oz drops
Marathon Group's Wholly Owned Subsidiary, MarathonRx, Has Signed a Manufacturing and Supply Agreement for a 1,500mg Nano-Pure Ultra CBD Drops Product, the First of Many Products (2/15/19)
https://finance.yahoo.com/news/marathon-groups-wholly-owned-subsidiary-211000958.html

A TechNavio report (https://www.technavio.com/report/global-cbd-oil-market-analysis-share-2018) indicates the CBD oil market is expected to grow by 31% year over year through 2022.

 A search on 
https://www.ncbi.nlm.nih.gov/pubmed/?term=cbd+oil for the term 'CBD oil' brings up a number of studies regarding the widespread benefits of CBD oil use.




 
CBD is readily obtainable in most parts of the United States, though its exact legal status is in flux. All 50 states have laws legalizing CBD with varying degrees of restriction, and while the federal government still considers CBD in the same class as marijuana, it doesn’t habitually enforce against it. 
Studies show - when treating some of the cruelest childhood epilepsy syndromes -  CBD was able to reduce the number of seizures, and in some cases it was able to stop them altogether. 





 

CBD has been shown to treat CHRONIC PAIN and ARTHRITIS 
 





 
CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis. 
Another study demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain, two of the most difficult types of chronic pain to treat. 






 

CBD has been shown to treat ALZHEIMER's and MULTIPLE SCLEROSIS
 






 

Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.

Several studies have demonstrated the therapeutic potential of cannabis and its derivate products to manage the symptoms of multiple sclerosis (MS) and other neurodegenerative diseases.








 


MarathonRx has laid the groundwork for a rapid move into the CBD field.
Discussions are already underway with various labs and suppliers
of top quality CBD products.






 









 



THE US CBD PRODUCT MARKET IS EXPANDING!!!!!!!!!



Image result for projected CBD market



 



You can stay up to date with our progress by visiting our website: 

 http://www.marathonrx.com 

and subscribing to our newsletter for updates.

 
PDPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#15146   Hmmm… But could be a wrecked restorable classic? Highlandmike 06/11/21 11:02:30 AM
#15145   PDPR shell will always have a stigma with it... thetinman 06/10/21 08:04:14 PM
#15144   no idea i_like_bb_stock 06/10/21 12:16:50 PM
#15143   Think someone will pick up the ticker? PDPR Highlandmike 06/10/21 12:09:07 PM
#15142   CEO has always been a POS.. and could thetinman 06/10/21 08:31:09 AM
#15141   I hope the CEO here has been arrested stockstobuy 06/09/21 02:07:40 PM
#15140   I think you are a few months behind calluch 06/09/21 01:24:22 PM
#15139   ZERO happening here with this pump / promoted stock.. thetinman 06/07/21 09:29:13 PM
#15138   Ugh i_like_bb_stock 05/30/21 04:00:22 PM
#15137   account blocked.Twitter blocks accounts that violate the Twitter TB 05/30/21 03:33:37 PM
#15136   Dissolution / Revocation - RA - 2021-003207351 Date: TB 05/30/21 03:29:22 PM
#15135   Pdpr shell will always be tainted bc of thetinman 05/27/21 08:48:29 PM
#15134   Probably the same way you.did 5 years ago calluch 05/27/21 05:30:05 PM
#15133   How'd you hear about pdpr in the first thetinman 05/27/21 05:28:00 PM
#15132   Why? Because they halted the stock for 10 calluch 05/27/21 05:24:15 PM
#15131   Why is the SEC to blame for pump thetinman 05/27/21 05:20:36 PM
#15130   Down to .0001 thanks to the sec. calluch 05/27/21 04:29:08 PM
#15129   lol i_like_bb_stock 05/06/21 03:45:05 PM
#15128   I’ll take a healthy run up to say, Highlandmike 05/06/21 03:39:23 PM
#15127   I know that feeling for 5 years then thetinman 05/03/21 02:30:12 PM
#15126   Hard to type when you are holding bags Kingaleks 05/03/21 08:57:17 AM
#15125   Where all the pdpr folks go? Lol thetinman 05/03/21 08:31:23 AM
#15124   Sorry to hear that. I made a very SwingLong 04/05/21 05:22:59 AM
#15122   Lmao at a pdpr PR from 5 thetinman 03/24/21 08:30:21 PM
#15121   more than that for me i_like_bb_stock 03/24/21 01:42:57 PM
#15120   I hope so... I’m in the hole 2g SwingLong 03/24/21 01:37:05 PM
#15119   I'd assume a reverse is coming next for pdpr thetinman 03/22/21 07:17:16 PM
#15118   Yes i_like_bb_stock 03/22/21 07:06:59 PM
#15117   FINALLY!! thetinman 03/22/21 06:09:23 PM
#15116   address change and registered agent resignation, I still i_like_bb_stock 03/22/21 06:07:28 PM
#15114   Glad SEC stepped in bc pdpr has been thetinman 03/20/21 09:00:20 PM
#15113   I'm out of this pumped stock that will thetinman 03/20/21 08:57:16 PM
#15111   you could have recoup all your investment and RammageRaul 03/11/21 07:18:27 PM
#15110   Let's make it easier, thetinman 03/11/21 07:03:32 PM
#15109   I have a pretty simple strategy load at RammageRaul 03/11/21 05:48:20 PM
#15108   Wow, such a great DEFLECTION to my one thetinman 03/11/21 05:00:18 PM
#15107   from 0001 to 006 thats about 60,000% in RammageRaul 03/11/21 02:04:00 PM
#15106   Lmao, still using the chart gig? thetinman 03/11/21 02:00:54 PM
#15105   thats why you dont invest in pinkyland you RammageRaul 03/11/21 01:56:35 PM
#15104   Glad I got out of pdpr as it thetinman 03/11/21 12:52:20 PM
#15103   And it never went anywhere like the rest thetinman 03/08/21 11:11:37 AM
#15102   Hahaha people got shafted on this play. .0003 hahaha. SwingLong 03/08/21 09:29:45 AM
#15101   Good idea calluch 03/07/21 06:47:24 PM
#15100   I’m going to buy this wazzufresh 03/05/21 11:26:54 PM
#15099   I found on SeekingAlpha a description of the iHubbub1 03/05/21 10:40:09 PM
#15098   They are really protecting us. Hahahhaha calluch 03/05/21 05:37:54 PM
#15097   Gotta love that SEC. They kept these stocks ThoroughBread 03/05/21 02:10:20 PM
#15096   So the interest here created the SEC investigation, Laylos 03/05/21 12:56:07 PM
#15095   What’s happening here? rowles5050 03/05/21 12:34:43 PM
#15094   guess we wait for EXPERT getmoreshares 03/05/21 11:39:15 AM
PostSubject
Consent Preferences